Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06438315
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-05-21
Brief Title:
SuperSaturated Oxygen Comprehensive Observational Registry
Sponsor:
TherOx
Organization:
TherOx
Study Overview
Official Title:
SuperSaturated Oxygen Comprehensive Observational Registry
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SSCORE
Brief Summary:
The SuperSaturated Oxygen Comprehensive Observational Registry SSCORE registry a prospectively designed observational study aims to evaluate the clinical utility and effectiveness of SuperSaturated Oxygen SSO2 Therapy versus percutaneous coronary intervention PCI alone among patients with anterior acute myocardial infarction AMI in routine clinical practice The goal is to collect real-world data from patients treated with SSO2 Therapy to determine its impact on the overall heart failure HF burden on patients and healthcare systems compared with usual care for treatment of patients with AMI The SSCORE Registry will generate effectiveness and healthcare resource utilization data that will be used in cost-effectiveness analysis modeling
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None